Case number 1:23-cv-01412
Par Pharmaceutical, Inc. et al v. Long Grove Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2024 | N/A | SO ORDERED, re 32 STIPULATION AND ORDER TO EXTEND TIME for Defendant to file its Reply Brief in further support of its Motion for Judgment on the Pleadings to through and including July 29, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 6/28/24. (jaa) (Entered: 06/28/2024) (0) |
| Jun 27, 2024 | 32 | STIPULATION TO EXTEND TIME for Defendant to file its Reply Brief in further support of its Motion for Judgment on the Pleadings to through and including July 29, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 06/27/2024) (1) |
| Jun 10, 2024 | N/A | SO ORDERED, re 31 STIPULATION TO EXTEND TIME to file Reply Brief in further support of its Motion for Judgment on the Pleadings (D.I. 18, 29) to June 27, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 6/10/2024. (lnb) (Entered: 06/10/2024) (0) |
| Jun 6, 2024 | 31 | STIPULATION TO EXTEND TIME to file Reply Brief in further support of its Motion for Judgment on the Pleadings (D.I. 18, 29) to June 27, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Farnan, Kelly) (Entered: 06/06/2024) (1) |
| May 30, 2024 | 30 | REDACTED VERSION of 27 Answering Brief in Opposition, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 05/30/2024) (26) |
| May 28, 2024 | N/A | SO ORDERED, re 29 STIPULATION TO EXTEND TIME to file its Reply Brief in further support of its Motion for Judgment on the Pleadings (D.I. 18) to June 13, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 5/28/2024. (lnb) (Entered: 05/28/2024) (0) |
| May 23, 2024 | 29 | STIPULATION TO EXTEND TIME to file its Reply Brief in further support of its Motion for Judgment on the Pleadings (D.I. 18) to June 13, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 05/23/2024) (1) |
| May 23, 2024 | 28 | DECLARATION re 27 Answering Brief in Opposition, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Exhibit A)(Ekiner, Kaan) (Entered: 05/23/2024) (0) |
| May 23, 2024 | 27 | [SEALED] ANSWERING BRIEF in Opposition re 18 MOTION for Judgment on the Pleadings filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.Reply Brief due date per Local Rules is 5/30/2024. (Ekiner, Kaan) (Entered: 05/23/2024) (0) |
| May 23, 2024 | 26 | ORDER re 25 Stipulation, filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. Signed by Judge Gregory B. Williams on 5/23/2024. (lnb) (Entered: 05/23/2024) (2) |
| May 22, 2024 | 25 | STIPULATION and Proposed Order for Plaintiffs to file their Response and any related papers to Defendant's Motion for Judgment on the Pleadings Under Seal by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 05/22/2024) (2) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Herve Jacquiau for Long Grove Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Sherry L. Rollo for Long Grove Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Steven E. Feldman for Long Grove Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 3, 2024 | 24 | REDACTED VERSION of 19 Opening Brief in Support, by Long Grove Pharmaceuticals, LLC. (Attachments: # 1 Exhibit A-D)(Farnan, Kelly) (Entered: 05/03/2024) (0) |
| Apr 29, 2024 | N/A | SO ORDERED, re 21 MOTION for Pro Hac Vice Appearance of Attorney Herve Jacquiau, Sherry L. Rollo, and Steven E. Feldman filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 4/29/2024. (Brown, Lisa) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | N/A | SO ORDERED, re 23 STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendant's Motion for Judgment on the Pleadings (D.I. 18) to May 23, 2024 filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. Signed by Judge Gregory B. Williams on 4/29/2024. (Brown, Lisa) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | N/A | SO ORDERED, re 20 STIPULATION TO EXTEND TIME for Defendant to submit a redacted version of its opening brief and exhibits (D.I.19) to through and including May 3, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 4/29/2024. (Brown, Lisa) (Entered: 04/29/2024) (0) |
| Apr 26, 2024 | 23 | STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendant's Motion for Judgment on the Pleadings (D.I. 18) to May 23, 2024 - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 04/26/2024) (2) |
| Apr 26, 2024 | 22 | Pro Hac Vice Fee - Credit Card Payment received for Herve Jacquiau, Sherry L. Rollo, and Steven E. Feldman. ( re 21 MOTION for Pro Hac Vice Appearance of Attorney Herve Jacquiau, Sherry L. Rollo, and Steven E. Feldman )( Payment of $ 150, receipt number ADEDC-4394091).(Metzler, Sara) (Entered: 04/26/2024) (0) |
| Apr 26, 2024 | 21 | MOTION for Pro Hac Vice Appearance of Attorney Herve Jacquiau, Sherry L. Rollo, and Steven E. Feldman - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 04/26/2024) (4) |
| Apr 26, 2024 | 20 | STIPULATION TO EXTEND TIME for Defendant to submit a redacted version of its opening brief and exhibits (D.I.19) to through and including May 3, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 04/26/2024) (1) |
| Apr 22, 2024 | N/A | SO ORDERED, re 17 STIPULATION and Proposed Order for Defendant to File its Opening Brief and any related papers Under Seal filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 4/22/24. (ntl) (Entered: 04/22/2024) (0) |
| Apr 19, 2024 | 17 | STIPULATION and Proposed Order for Defendant to File its Opening Brief and any related papers Under Seal by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 04/19/2024) (2) |
| Apr 19, 2024 | 18 | MOTION for Judgment on the Pleadings - filed by Long Grove Pharmaceuticals, LLC. (Attachments: # 1 Text of Proposed Order)(Farnan, Kelly) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 19 | [SEALED] OPENING BRIEF in Support re 18 MOTION for Judgment on the Pleadings filed by Long Grove Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 5/3/2024. (Attachments: # 1 Exhibit A-D)(Farnan, Kelly) (Entered: 04/19/2024) (0) |
| Feb 27, 2024 | N/A | SO ORDERED, re 15 MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman and Sherry L. Rollo filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 2/27/24. (ntl) (Entered: 02/27/2024) (0) |
| Feb 26, 2024 | 16 | Pro Hac Vice Fee - Credit Card Payment received for Steven E. Feldman and Sherry L. Rollo. ( re 15 MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman and Sherry L. Rollo )( Payment of $ 100, receipt number ADEDC-4347869).(Metzler, Sara) (Entered: 02/26/2024) (0) |
| Feb 26, 2024 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman and Sherry L. Rollo - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 02/26/2024) (3) |
| Feb 26, 2024 | N/A | CORRECTING ENTRY: Corrected Answer added to D.I. 9 per request of counsel. (ntl) (Entered: 02/26/2024) (0) |
| Feb 15, 2024 | 14 | REDACTED VERSION of 9 Answer to Complaint by Long Grove Pharmaceuticals, LLC. (Attachments: # 1 Exhibit A-O)(Farnan, Kelly) (Entered: 02/15/2024) (0) |
| Feb 9, 2024 | N/A | SO ORDERED, re 13 STIPULATION TO EXTEND TIME for Defendant to submit a redacted version of its Answer and Defenses to Complaint (D.I.9) to February 15, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 2/9/24. (ntl) (Entered: 02/09/2024) (0) |
| Feb 8, 2024 | 13 | STIPULATION TO EXTEND TIME for Defendant to submit a redacted version of its Answer and Defenses to Complaint (D.I.9) to February 15, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 02/08/2024) (1) |
| Feb 7, 2024 | N/A | Pro Hac Vice Attorney Keri L. Schaubert, Aaron S. Lukas, William B. Coblentz, and Kerry B. McTigue for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., and Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 02/07/2024) (0) |
| Feb 6, 2024 | N/A | SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. Signed by Judge Gregory B. Williams on 2/5/24. (ntl) (Entered: 02/06/2024) (0) |
| Feb 2, 2024 | 12 | Pro Hac Vice Fee - Credit Card Payment received for Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert )( Payment of $ 200, receipt number ADEDC-4329839).(Ekiner, Kaan) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 02/02/2024) (6) |
| Feb 1, 2024 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Long Grove Pharmaceuticals Holdings, LLC for Long Grove Pharmaceuticals, LLC filed by Long Grove Pharmaceuticals, LLC. (Farnan, Kelly) (Entered: 02/01/2024) (1) |
| Feb 1, 2024 | 9 | [SEALED] ANSWER to 1 Complaint, by Long Grove Pharmaceuticals, LLC. (Attachments: # 1 Exhibit A-O)(Farnan, Kelly) (Main Document 9 replaced on 2/26/2024) (ntl). (Entered: 02/01/2024) (0) |
| Jan 2, 2024 | N/A | SO ORDERED, re 8 STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to the Complaint to February 1, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 1/2/24. (ntl) (Entered: 01/02/2024) (0) |
| Dec 29, 2023 | 8 | STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to the Complaint to February 1, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Farnan, Kelly) (Entered: 12/29/2023) (1) |
| Dec 13, 2023 | 7 | SUMMONS Returned Executed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC.Long Grove Pharmaceuticals, LLC served on 12/11/2023, answer due 1/2/2024. (Ekiner, Kaan) (Entered: 12/13/2023) (2) |
| Dec 13, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 12/13/2023) (0) |
| Dec 8, 2023 | 6 | Summonses Issued (please complete the top portion of the form and print out for use/service). (jfm) (Entered: 12/08/2023) (2) |
| Dec 8, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Par Pharmaceutical, Inc. for Endo Par Innovation Company, LLC and Par Sterile Products, LLC; Corporate Parent Endo International PLC for Par Pharmaceutical, Inc. filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(jfm) (Entered: 12/08/2023) (2) |
| Dec 8, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,993,520; US 11,207,372. (jfm) (Entered: 12/08/2023) (1) |
| Dec 8, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: January 30, 2035. Thirty Month Stay Deadline: N/A (jfm) (Entered: 12/08/2023) (1) |
| Dec 8, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 12/08/2023) (3) |
| Dec 8, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Long Grove Pharmaceuticals, LLC (Filing fee $ 405, receipt number ADEDC-4290738.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jfm) (Entered: 12/08/2023) (0) |
